|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61K 31/445 | (2006.01) |
| (11) | Number of the document | 1414451 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02756988.8 |
| Date of filing the European patent application | 2002-08-06 | |
| (97) | Date of publication of the European application | 2004-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2009-05-20 |
| (46) | Date of publication of the claims translation | 2009-09-25 |
| (86) | Number | PCT/US2002/024944 |
| Date | 2002-08-06 |
| (87) | Number | WO 2003/013525 |
| Date | 2003-02-20 |
| (30) | Number | Date | Country code |
| 310536 P | 2001-08-06 | US |
| (72) |
BREDER, Christopher, US
OSHLACK, Benjamin, US
WRIGHT, Curtis, US
|
| (73) |
EURO-CELTIQUE S.A.,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Opioidų agonisto kompozicijos su atpalaiduojamu izoliuotu antagonistu |
| OPIOID AGONIST FORMULATIONS WITH RELEASABLE AND SEQUESTERED ANTAGONIST |
| Payment date | Validity (years) | Amount | |
| 2018-07-19 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-08-06 |